Skip to content

Noninvasive Assessment of Tissue Perfusion Status in Critically Ill Pediatric Patients

Noninvasive Assessment of Tissue Perfusion Status in Critically Ill Pediatric Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01760044
Enrollment
46
Registered
2013-01-03
Start date
2013-01-31
Completion date
2014-11-30
Last updated
2017-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis, Shock

Keywords

tissue oxygenation, perfusion status

Brief summary

Investigators are conducting research about oxygen levels in the body and whether it is possible to use a device to measure oxygen in the body's tissues noninvasively, without blood draws or a catheter (a plastic tube placed in a vein). Investigators would like to know how this device compares to standard measurements using blood from a catheter. This may help treat patients who may not be getting enough oxygen to their body.

Detailed description

Investigators will enroll patients in the pediatric intensive care unit who have an indwelling catheter that allows measurement of central venous oxygen saturation. Measurements of central venous oxygen saturation using blood oximetry will be compared with measures of tissue oxygenation at the buccal mucosa using a Raman spectroscopy tissue oximeter. Investigators will also measure the status of the sublingual microcirculation utilizing sidestream dark field microscopy. Basic demographic and clinical variables such as ongoing vasoactive infusions, mechanical ventilation, and laboratory data will also be collected.

Interventions

The device provides continuous measures with updates based on the previous 10 seconds worth of data. Data is continuously stored.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Days to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patients admitted to the Pediatric Intensive Care Unit (PICU) or Pediatric Cardiothoracic Unit (PCTU) * Age \>30 days and \<18 years -patients with a high central venous line (ie internal jugular, subclavian, peripherally inserted central catheter, broviac, port) capable of blood draw and with central venous catheter tip in the superior vena cava

Exclusion criteria

* Age \<30 days or \>18 years * Known pregnancy or subsequently discovered pregnancy after admission * Uncorrected cyanotic congenital heart disease Relative

Design outcomes

Primary

MeasureTime frameDescription
tissue oxygenation level as measured by raman spectroscopy deviceThe measures will occur twice within the first 24 hours of admission to the pediatric ICU and then whenever a central venous oxygen saturation is measured by the clinical care team until the patient is discharged from the pediatric ICU.Measurement of tissue oxygenation level as based upon raman spectroscopy device will be compared with standard measures from central venous oxygen saturation from central venous catheters.

Secondary

MeasureTime frameDescription
Microcirculation as recorded by sublingual video microcirculation recorder.Twice in the first 24 hours after PICU admissionTwo video clips will be recorded of the sublingual microcirculation in each patient within the first 24 hours of admission to the PICU.
Vital signs as recorded by Bioinformatically enabled armband monitor (BEAM)Continuous from PICU admission through 24 hours of admissionBioinformatically enabled armband monitor (BEAM) will be placed on the patient's upper extremity for the first 24 hours of their admission and will be subsequently removed. The data will be stored in the device and investigators and clinicians caring for subjects will be blinded to the device output as data is collected. The device continually captures physiologic data such as heart rate, ECG results, and temperature.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026